Zura Bio Limited (ZURA) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ZURA is $15.00, representing a +162.2% upside from the current price of $5.72. Price targets range from a low of $15.00 to a high of $15.00.